Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
FSHD Header Logo
mobile-logo

  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
          • Financials
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Journey To A Cure
          • 2022 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torchbearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • What is a Clinical Trial?
          • Your Involvement Matters
          • Current Trials & Studies
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • World FSHD Day
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Current Trials and Studies
        • For Researchers
          • Apply for a Grant
          • Research We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • For Industry
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Voice of the Patient Report
          • Project Mercury
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • Search
  • Financials
  • Patient Library
  • Blog
  • Calendar
  • JOIN US
  • Donate
  • JOIN US
  • Donate

A new way to detect DUX4

Home / FSHD Research / A new way to detect DUX4

Posted on: Aug 05, 2019

by Gholamhossein Amini Chermahini, MD, Columbus, Ohio

Editor’s Note: Dr. Amini Chermahini and his colleagues were awarded the Best Poster Prize at this year’s FSHD International Research Congress. Here he explains the significance of this work.

The FSHD field has made tremendous progress during the last decade or so, beginning with the identification of the DUX4 gene as a root cause of the disease. Several new experimental FSHD therapies are emerging, and most are designed to turn DUX4 “off” or reduce its levels.

As these new treatments reach human clinical trials, it becomes important for clinicians to have “outcome measures” that can be used to determine if a treatment is working or not. One such outcome measure could detect whether a drug has reduced the amount of DUX4 present in a treated muscle compared to an untreated muscle. Unfortunately, because DUX4 is only active in one out of a thousand muscle nuclei at a given time, it is like searching for the proverbial needle in a haystack. It is difficult to find and detect, and to our knowledge there were no established methods to reliably measure DUX4 in human muscles.

The goal of our study was to test a new and highly sensitive method to detect DUX4. In our RNAscope assay, an RNA in situ hybridization (ISH) technology, several probes* target the specific area in tandem on the mRNA (messenger RNA),** which increases the specificity of DUX4 detection. At the time we began this study, the vendor had not developed DUX4-targeted RNAscope probes and we therefore initiated our study using custom-designed DUX4 RNAscope probes. We found that this method was capable of detecting very low levels of DUX4 in isolated FSHD muscle cells grown in the lab (Fig 1). Importantly, we also found that this approach could measure reductions in DUX4 after FSHD muscle cells were exposed to an experimental therapy.

This study is published now in the RNA journal (2019) titled “RNAscope in situ hybridization-based method for detecting DUX4 RNA expression in vitro” and also was presented at the IRC 2019 in Marseille. We were honored to receive the “Best Poster Prize,” which is very encouraging and at the same time testifies to the importance of the subject in the field. The next step of this study is to determine if the method will work in muscle biopsies donated by FSHD patients. If so, we propose that it may be useful as an outcome measure in future clinical trials.

myotubes
Figure 1. FSHD myotubes demonstrated higher amounts of DUX4 mRNA (brown stains in top image) compared to non-FSHD myotubes (bottom image).

*Probe. A fragment of RNA or DNA that recognizes part of the genetic sequence of DUX4 and binds to it, like a key fitting a lock. A radioactive or fluorescent tracer on the probe then enables the probe to be detected.

**mRNA. Genetic information flows from DNA to RNA to protein. The first step employs a process called transcription to read a strand of DNA and synthesize a corresponding piece of messenger RNA (mRNA); the second step employs a process called translation to read that piece of mRNA and build a corresponding protein.

Share

Filed Under: FSHD Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH

Categories

  • FSHD Research
  • FSHD Society News
    • Extraordinary Measures
    • Journey to a Cure
  • Fundraising & Events
  • General
  • Living with FSHD
    • Health and Medicine
    • Mental Health
    • PT and Exercise
    • Tips and Tricks
  • Media & PR

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

Mail Donations to:

FSHD Society
P.O. Box 411617
Boston, MA 02241-1617

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by